Semax 1% 3 ml.

Description

Semax 1% 3 ml Solution

Manufacturer

• Produced by: Institute of Molecular Genetics (IMG) of the Russian Academy of Sciences.
• Country of Origin: Russia
• Distributed by: Authorized distributors in specific regions.

Composition

• Each 3 ml solution contains:
  • Active ingredient: Semax (synthetic analogue of ACTH(4-10) peptide) – 1% concentration (10 mg/ml).
  • Excipients: Water for injection, methylparaben, and sodium chloride (for isotonicity).

Indications

Semax is a nootropic medication designed to improve cognitive functions and neuroprotection. It is indicated for:

• Treatment of acute ischemic stroke as part of comprehensive therapy.
• Restoration of cognitive functions after traumatic brain injury (TBI).
• Management of cerebrovascular disorders, including chronic ischemia.
• Neuroprotection in patients undergoing surgical interventions involving the brain.
• Supportive therapy for memory, attention, and concentration improvement in cognitive impairments.
• Prevention of stress-related mental exhaustion in high-stress conditions.

Dosage and Administration

• Administration route: Intranasal (nasal drops) only.
• Dosage:
  • Acute ischemic stroke: 3-4 drops in each nostril, 4-6 times daily for 10 days.
  • Cognitive impairments: 2-3 drops in each nostril, 2-3 times daily for 5-14 days.
  • Prevention of stress or mental fatigue: 1-2 drops in each nostril, 2 times daily for 3-5 days.
• Application: Administer the drops evenly into both nostrils. The patient should tilt their head slightly backward during application.
• Duration of therapy: Depending on the condition, the treatment course may vary between 5 and 14 days.

Contraindications

Semax is contraindicated in the following conditions:

• Known hypersensitivity to Semax or any of the excipients in the formulation.
• Acute psychosis or severe mental disorders.
• Severe renal or hepatic impairment (precaution advised).
• Pediatric use in children under 7 years of age (1% concentration).

Precautions and Warnings

• Use with caution in patients with chronic psychiatric conditions.
• Monitor neurological and cognitive functions throughout treatment for optimal therapeutic outcomes.
• Semax has no known sedative effect, but individual sensitivity may vary; avoid operating machinery or driving if dizziness occurs.
• Consult a healthcare professional before using Semax in combination with other nootropics or neuroprotective agents.

Adverse Effects

Semax is generally well-tolerated, but some patients may experience mild side effects, including:

• Local reactions: Nasal irritation, dryness, or mild burning sensation.
• Neurological effects: Headache, dizziness, or irritability (rare).
• Allergic reactions: Skin rash, itching, or other hypersensitivity symptoms (very rare).

Drug Interactions

• No significant interactions with other medications have been reported.
• May enhance the effects of other nootropic medications when used concurrently.
• Consult your healthcare provider before combining Semax with any other drugs or supplements.

Pregnancy and Lactation

Semax is not recommended during pregnancy or lactation due to insufficient data on safety. Use only if the potential benefits outweigh the risks, as determined by a healthcare professional.

Overdose

In case of overdose, symptoms such as nasal irritation or mild headache may occur. These effects are usually self-limiting and do not require specific treatment. Supportive care may be provided if needed.

Storage

• Store at a temperature of 2-8°C (refrigerated). Do not freeze.
• Protect from direct sunlight and moisture.
• After opening, use within 30 days.
• Keep out of reach of children.

Patient Information

Patients should be informed about the purpose of the treatment and the correct method of administration. Any unusual symptoms or adverse reactions should be reported to a healthcare provider immediately. Semax should only be used under the supervision of a qualified healthcare professional.